511 Therapeutics, Inc., 2026-10-30
A new SEC Form D private-offering notice from Cambridge, MA, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Biotech developing self-assembling peptide nanomaterials and engineered water-soluble membrane proteins, co-founded by MIT's Shuguang Zhang to commercialize his peptide nanobiotechnology research.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Betvisors, Inc., 2026-10-30, $150K, Boston, MA
- Palimpsest Bio Corp., 2026-10-30, $1M, Las Vegas, NV
- Tru Singular Health, Inc., 2026-10-30, $1M, Natick, MA
- Synomis, Inc., 2026-10-30, $2.5M, Germantown, TN
- RESOLV TECHNOLOGY, INC., 2026-10-30, $10M, Manchester, MA
- Drowsy Digital, Inc., 2026-10-29, $40.4M, Marlborough, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.